NeuroScientific Biopharmaceuticals Limited (ASX:NSB)
Australia flag Australia · Delayed Price · Currency is AUD
0.1400
+0.0050 (3.70%)
Jan 30, 2026, 4:10 PM AEST

ASX:NSB Ratios and Metrics

Millions AUD. Fiscal year is Jul - Jun.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 20212016 - 2020
Period Ending
Jan '26 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21 2016 - 2020
47296112648
Upgrade
Market Cap Growth
794.40%400.23%-49.60%-55.56%-46.27%222.72%
Upgrade
Enterprise Value
3924281643
Upgrade
Last Close Price
0.140.090.040.080.180.34
Upgrade
PE Ratio
--17.84---
Upgrade
PS Ratio
--2.622.32-50.13
Upgrade
PB Ratio
2.771.721.082.444.683.29
Upgrade
P/TBV Ratio
6.423.991.172.604.973.38
Upgrade
P/FCF Ratio
--136.31---
Upgrade
P/OCF Ratio
--130.72---
Upgrade
EV/Sales Ratio
--1.111.65-44.93
Upgrade
EV/EBITDA Ratio
--9.93---
Upgrade
EV/EBIT Ratio
--15.76---
Upgrade
EV/FCF Ratio
--57.68---
Upgrade
Asset Turnover
--0.410.76-0.10
Upgrade
Quick Ratio
49.3549.3558.468.303.3163.61
Upgrade
Current Ratio
49.5649.5658.878.393.3464.58
Upgrade
Return on Equity (ROE)
-16.65%-16.65%6.46%-20.93%-103.71%-34.82%
Upgrade
Return on Assets (ROA)
-11.21%-11.21%1.81%-11.24%-58.19%-21.98%
Upgrade
Return on Capital Employed (ROCE)
-11.90%-11.90%2.90%-25.00%-190.30%-22.40%
Upgrade
Earnings Yield
-3.96%-6.38%5.61%-9.31%-40.41%-6.61%
Upgrade
FCF Yield
--3.25%0.73%-20.08%-26.90%-5.47%
Upgrade
Buyback Yield / Dilution
-1.49%-1.49%-0.72%---83.04%
Upgrade
Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.